AbbVie Inc Issues FY 2013 EPS Guidance In Line With Analysts' Estimates
AbbVie Inc announced that for fiscal 2013, it expects adjusted earnings per share (EPS) guidance of $3.03 to $3.13, or $2.66 to $2.76 on a Generally Accepted Accounting Principles (GAAP) basis. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.08 for fiscal 2013.
Latest Key Developments in Pharmaceuticals
- Valeant Pharmaceuticals International Inc Near Deal To Acquire Bausch & Lomb From Warburg Pincus LLC-Reuters
- Valeant Pharmaceuticals International Inc Near Deal To Acquire Bausch & Lomb-Reuters
- Astec LifeSciences Ltd Recommends Dividend; Announces Appointment Of Statutory Auditors
- J B Chemicals and Pharmaceuticals Ltd Recommends Dividend
- Share this
- Link this
- Digg this
Follow Reuters